Share on:
BLUEVAC– 3® is the first BTV-3 vaccine that has demonstrated to reduce viremia in both sheep and cattle.
Recent outbreaks of BTV-3 in the Netherlands, Belgium, and Germany caused severe losses for farmers and are threatening neighbouring countries. The newly emerged serotype 3 that is currently spreading in Europe was reported to impact sheep farms with a weekly mortality rate close to 2.5%1. In cattle, the recent BTV-3 outbreak has led to symptoms like reproductive disorders and is associated to significant milk losses in affected dairy farms2. In addition to the impact on the animals, bluetongue virus can cause severe economic losses for producers, impacting the international trade.
Transmitted by mosquitos, it is a seasonal disease linked to the activity of its vector. Therefore, after a low incidence in winter and spring, it is anticipated an increased incidence in summer and autumn.
To support our customers and authorities in the fight against this devastating disease, Ceva has partnered with CZV Vaccines to make this vaccine available to German veterinarians and farmers.
The vaccine has been licensed for exceptional use in Germany and is available starting in July, 2024.
Juan Munoz Bielsa, Ceva’s Corporate Ruminants Marketing Director, says: “In cooperation with our partner CZV Vaccines, we are happy to support veterinarians and farmers, by making available on the market a very effective vaccine against bluetongue serotype3, within a very short period of time. BLUEVAC-3 is the first vaccine to reduce viremia in both cattle and sheep which is essential to control the disease. This vaccine is an essential tool to protect cattle and sheep under our care”.
References:
1.- Inge Santman Berends and René Van der Brom, AHDB technical Webinar 7th of February 2024, Bluetongue virus technical webinar – Insights from the Netherlands on the 2023 outbreak – YouTube
2.- Highlights Report Cattle, April 2024. Monitoring Animal Health. GD 3020/04/24. Accessed at Highlights report cattle: BTV3-outbreak update: clinical symptoms, pathology and impact analysis (gddiergezondheid.nl)